NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nexus NeuroTech Ventures

Nexus NeuroTech Ventures

San Francisco, Californianexusneurotech.com

Overview

Nexus NeuroTech Ventures is dedicated to advancing pioneering technologies — including medical devices, software, diagnostics, technology-enabled care services and research tools — for brain disorders. Spanning seed through crossover, Nexus invests with the goal of improving the lives of people affected by neurodevelopmental, neurodegenerative and neuropsychiatric conditions.

Year Founded

2023

Portfolio Companies

16

Investments

Nexus NeuroTech Ventures investments
CompanyDateStageLead
Beacon BiosignalsApr 2026Series B ExtensionCo-investor
NeuraWorx Medical TechnologiesDec 2025SeedLead
Lotus NeuroDec 2025Corporate FundingLead
Beacon BiosignalsNov 2025Series BCo-investor
Modulight BiotherapeuticsNov 2025SeedCo-investor

Key People

Jordi Parramon

CEO, General Partner and Co-founder

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.